IPSEN (IPN.PA) Fundamental Analysis & Valuation

EPA:IPN • FR0010259150

Current stock price

157.7 EUR
+4.9 (+3.21%)
Last:

This IPN.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. IPN.PA Profitability Analysis

1.1 Basic Checks

  • In the past year IPN was profitable.
  • In the past year IPN had a positive cash flow from operations.
  • Each year in the past 5 years IPN has been profitable.
  • IPN had a positive operating cash flow in each of the past 5 years.
IPN.PA Yearly Net Income VS EBIT VS OCF VS FCFIPN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

1.2 Ratios

  • IPN's Return On Assets of 11.21% is fine compared to the rest of the industry. IPN outperforms 76.47% of its industry peers.
  • With a decent Return On Equity value of 17.93%, IPN is doing good in the industry, outperforming 70.59% of the companies in the same industry.
  • With an excellent Return On Invested Capital value of 21.54%, IPN belongs to the best of the industry, outperforming 88.24% of the companies in the same industry.
Industry RankSector Rank
ROA 11.21%
ROE 17.93%
ROIC 21.54%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IPN.PA Yearly ROA, ROE, ROICIPN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20 25

1.3 Margins

  • The Profit Margin of IPN (13.25%) is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of IPN has declined.
  • The Operating Margin of IPN (25.32%) is better than 64.71% of its industry peers.
  • IPN's Operating Margin has been stable in the last couple of years.
  • IPN's Gross Margin of 81.66% is amongst the best of the industry. IPN outperforms 86.27% of its industry peers.
  • IPN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 25.32%
PM (TTM) 13.25%
GM 81.66%
OM growth 3Y-3.38%
OM growth 5Y-1.48%
PM growth 3Y-18.1%
PM growth 5Y-11.16%
GM growth 3Y-0.97%
GM growth 5Y-0.21%
IPN.PA Yearly Profit, Operating, Gross MarginsIPN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. IPN.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), IPN is creating value.
  • IPN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IPN.PA Yearly Shares OutstandingIPN.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
IPN.PA Yearly Total Debt VS Total AssetsIPN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • IPN has an Altman-Z score of 4.93. This indicates that IPN is financially healthy and has little risk of bankruptcy at the moment.
  • IPN has a Altman-Z score of 4.93. This is in the better half of the industry: IPN outperforms 72.55% of its industry peers.
  • The Debt to FCF ratio of IPN is 1.18, which is an excellent value as it means it would take IPN, only 1.18 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of IPN (1.18) is better than 92.16% of its industry peers.
  • IPN has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
  • IPN's Debt to Equity ratio of 0.19 is fine compared to the rest of the industry. IPN outperforms 76.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.18
Altman-Z 4.93
ROIC/WACC2.66
WACC8.11%
IPN.PA Yearly LT Debt VS Equity VS FCFIPN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

  • IPN has a Current Ratio of 1.96. This is a normal value and indicates that IPN is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.96, IPN is in the better half of the industry, outperforming 70.59% of the companies in the same industry.
  • A Quick Ratio of 1.79 indicates that IPN should not have too much problems paying its short term obligations.
  • IPN's Quick ratio of 1.79 is amongst the best of the industry. IPN outperforms 80.39% of its industry peers.
Industry RankSector Rank
Current Ratio 1.96
Quick Ratio 1.79
IPN.PA Yearly Current Assets VS Current LiabilitesIPN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. IPN.PA Growth Analysis

3.1 Past

  • IPN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.24%, which is quite good.
  • IPN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.79% yearly.
  • Looking at the last year, IPN shows a very strong growth in Revenue. The Revenue has grown by 64.12%.
  • Measured over the past years, IPN shows a small growth in Revenue. The Revenue has been growing by 5.83% on average per year.
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%9.65%
Revenue 1Y (TTM)64.12%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%1.83%

3.2 Future

  • The Earnings Per Share is expected to grow by 6.81% on average over the next years.
  • IPN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.47% yearly.
EPS Next Y10.9%
EPS Next 2Y9%
EPS Next 3Y7.04%
EPS Next 5Y6.81%
Revenue Next Year8.75%
Revenue Next 2Y8.37%
Revenue Next 3Y7.29%
Revenue Next 5Y6.47%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
IPN.PA Yearly Revenue VS EstimatesIPN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B 4B
IPN.PA Yearly EPS VS EstimatesIPN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10

More info and screens

Find the best growth stocksShow best growing peers

6

4. IPN.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 15.36, which indicates a correct valuation of IPN.
  • Based on the Price/Earnings ratio, IPN is valued a bit cheaper than 68.63% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of IPN to the average of the S&P500 Index (24.88), we can say IPN is valued slightly cheaper.
  • Based on the Price/Forward Earnings ratio of 12.93, the valuation of IPN can be described as correct.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of IPN indicates a somewhat cheap valuation: IPN is cheaper than 76.47% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, IPN is valued a bit cheaper.
Industry RankSector Rank
PE 15.36
Fwd PE 12.93
IPN.PA Price Earnings VS Forward Price EarningsIPN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20

4.2 Price Multiples

  • 94.12% of the companies in the same industry are more expensive than IPN, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, IPN is valued cheaply inside the industry as 80.39% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 15.96
EV/EBITDA 5.99
IPN.PA Per share dataIPN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • IPN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • IPN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.41
PEG (5Y)1.75
EPS Next 2Y9%
EPS Next 3Y7.04%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. IPN.PA Dividend Analysis

5.1 Amount

  • IPN has a yearly dividend return of 0.92%, which is pretty low.
  • Compared to an average industry Dividend Yield of 1.89, IPN has a dividend in line with its industry peers.
  • With a Dividend Yield of 0.92, IPN pays less dividend than the S&P500 average, which is at 1.89.
Industry RankSector Rank
Dividend Yield 0.92%

5.2 History

  • The dividend of IPN has a limited annual growth rate of 3.72%.
Dividend Growth(5Y)3.72%
Div Incr Years1
Div Non Decr Years4
IPN.PA Yearly Dividends per shareIPN.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • 14.95% of the earnings are spent on dividend by IPN. This is a low number and sustainable payout ratio.
  • IPN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP14.95%
EPS Next 2Y9%
EPS Next 3Y7.04%
IPN.PA Yearly Income VS Free CF VS DividendIPN.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M
IPN.PA Dividend Payout.IPN.PA Dividend Payout, showing the Payout Ratio.IPN.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

IPN.PA Fundamentals: All Metrics, Ratios and Statistics

IPSEN

EPA:IPN (3/27/2026, 7:00:00 PM)

157.7

+4.9 (+3.21%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-12
Earnings (Next)07-29
Inst Owners15.77%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap13.22B
Revenue(TTM)5.87B
Net Income(TTM)777.50M
Analysts68.42
Price Target153.26 (-2.82%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.92%
Yearly Dividend1.2
Dividend Growth(5Y)3.72%
DP14.95%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.45%
PT rev (3m)16.2%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)6.97%
EPS NY rev (3m)9.96%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.45%
Revenue NY rev (3m)4.05%
Valuation
Industry RankSector Rank
PE 15.36
Fwd PE 12.93
P/S 2.25
P/FCF 15.96
P/OCF 11.43
P/B 3.05
P/tB 9.35
EV/EBITDA 5.99
EPS(TTM)10.27
EY6.51%
EPS(NY)12.2
Fwd EY7.74%
FCF(TTM)9.88
FCFY6.26%
OCF(TTM)13.8
OCFY8.75%
SpS70
BVpS51.74
TBVpS16.87
PEG (NY)1.41
PEG (5Y)1.75
Graham Number109.34
Profitability
Industry RankSector Rank
ROA 11.21%
ROE 17.93%
ROCE 27.02%
ROIC 21.54%
ROICexc 29.88%
ROICexgc 113.42%
OM 25.32%
PM (TTM) 13.25%
GM 81.66%
FCFM 14.11%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-3.38%
OM growth 5Y-1.48%
PM growth 3Y-18.1%
PM growth 5Y-11.16%
GM growth 3Y-0.97%
GM growth 5Y-0.21%
F-Score7
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.18
Debt/EBITDA 0.4
Cap/Depr 52.58%
Cap/Sales 5.6%
Interest Coverage 250
Cash Conversion 54.79%
Profit Quality 106.48%
Current Ratio 1.96
Quick Ratio 1.79
Altman-Z 4.93
F-Score7
WACC8.11%
ROIC/WACC2.66
Cap/Depr(3y)123.84%
Cap/Depr(5y)123.25%
Cap/Sales(3y)11.93%
Cap/Sales(5y)11.8%
Profit Quality(3y)111.08%
Profit Quality(5y)104.31%
High Growth Momentum
Growth
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%9.65%
EPS Next Y10.9%
EPS Next 2Y9%
EPS Next 3Y7.04%
EPS Next 5Y6.81%
Revenue 1Y (TTM)64.12%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%1.83%
Revenue Next Year8.75%
Revenue Next 2Y8.37%
Revenue Next 3Y7.29%
Revenue Next 5Y6.47%
EBIT growth 1Y87.65%
EBIT growth 3Y3.94%
EBIT growth 5Y6.31%
EBIT Next Year33.03%
EBIT Next 3Y12.65%
EBIT Next 5Y10.42%
FCF growth 1Y522.48%
FCF growth 3Y4.75%
FCF growth 5Y5.6%
OCF growth 1Y26.34%
OCF growth 3Y5.92%
OCF growth 5Y8.44%

IPSEN / IPN.PA Fundamental Analysis FAQ

What is the fundamental rating for IPN stock?

ChartMill assigns a fundamental rating of 6 / 10 to IPN.PA.


What is the valuation status of IPSEN (IPN.PA) stock?

ChartMill assigns a valuation rating of 6 / 10 to IPSEN (IPN.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for IPSEN?

IPSEN (IPN.PA) has a profitability rating of 6 / 10.


What is the financial health of IPSEN (IPN.PA) stock?

The financial health rating of IPSEN (IPN.PA) is 7 / 10.


How sustainable is the dividend of IPSEN (IPN.PA) stock?

The dividend rating of IPSEN (IPN.PA) is 4 / 10 and the dividend payout ratio is 14.95%.